Zeynep: Health Ministry Takes Measures or Responsibilities

Despite the fact that the state's drug budget is forced to purchase for public system patients has increased by 2016, hospital conditions are not serious. Such a thing, according to “Democracy Plus”, Isuf Zana, relates to many factors, writes Koha Ditore today. One of [...]
Such a thing, according to “Democracy Plus”, Isuf Zana, relates to many factors, writes Koha Ditore today.
One of the factors, according to him, is not the lack of budget, but the neglect in linking and managing contracts related to drug supplies and spending material.
In the week's interview, Zeynep has found it necessary to address those in charge who are causing serious drug shortages from time to time. According to him, the responsibility should be addressed to officials who have contributed to the poor supply of drugs, or Minister Uran Ismaili must be taken responsibility himself.
According to Zeynep, the issue of concern is how drug contracts are managed. It has given them the right “to” that the new management has improved public promotion, but there are not many results in substantial changes in the way the public health system is working. He has also commented on contracting for drugs for a year that, according to him, has contributed to the unstable supply of drugs.
KD: Public Health is one of the most critical sectors in recent weeks. How do you view these developments?
Zeynep: In the Ministry of Health, there has been a series of reforms that have been undertaken and in many cases increased the quality of health services, as well as the costs of buying drugs for a string of articles.
There has also been an initiative to regulate the price of drugs through secondary legislation that makes the purchase of drugs in public procurement and not only predictable in financial costs.
However, major problems remain in contract management, initiating new contracts, when they are close to completion and others. An issue of concern is also management of drug and saving stocks, as there is no drug use system from the economic operator to the patient.











